研究单位：[1]Peking University Third Hospital,Peking University Third Hospital[2]Peking University First Hospital[3]Air Force Military Medical University, China[4]Beijing Hospital of Traditional Chinese Medicine[5]Xuanwu Hospital, Beijing[6]Air Force Medical Center, PLA,Beijing 1816670,China[7]Beijing Hospital of Traditional Chinese Medicine, Capital Medical University,Beijing 1816670,China[8]Peking University First Hospital,Beijing 1816670,China[9]Xuanwu Hospital, Capital Medical University,Beijing 1816670,China
This multicenter RCT aims to compare the efficacy and safety of Brivudine versus Famciclovir in treating acute herpes zoster. Primary objective: Evaluate pain reduction via Numeric Pain Rating Scale (NPRS) at Day 30. Secondary objectives: Compare NPRS at Day 3/Day 7/Day 14/Day 90, time to lesion resolution, Postherpetic Neuralgia (PHN) incidence, and safety.
